The nation of Zimbabwe has turned down a substantial American health deal worth $367m (£272m) over five years over the United States' insistence on confidential information.
The decision was revealed following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
A government representative has since explained that the United States was requesting biological samples for scientific study and profit but was not willing to share the benefits from any future treatments.
"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for more dialogue to find a deal acceptable to both sides so the nation's vital HIV treatment initiative can proceed.
Broader Background
This development follows a similar case in neighbouring Kenya, where a court halted a related health funding agreement following legal challenges were raised about the safety of Kenyans' health data.
Since returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had managed aid for the American government, but Trump stated its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and accountability.
According to reports, 16 nations in Africa have so far signed these new agreements, representing over $18.3bn in new funding.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"In essence, our country would supply the raw materials for medical research without any certainty that the end products would be available to our population if a future disease outbreak emerge."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting structures previously established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.
"This mechanism is intended to guarantee that when a nation contributes its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to ongoing discussions with our US partners on how future collaboration could be designed in a way that honours the independence and dignity of both nations."
Medical Community Response
A leading public health body stated it understood the official position, but urged that negotiations need to persist given that much of the nation's Aids initiatives relied on foreign aid.
"Where specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," it said.
This impasse highlights the ongoing tensions between receiving much-needed foreign assistance and protecting local interests in an ever more interconnected world.